Chronic obstructive pulmonary disease: Effects beyond the lungs

PLoS Medicine

Volumn 7, Issue 3, 2010, Pages 1-4

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SERUM AMYLOID A; SURFACTANT PROTEIN D; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY OBSTRUCTION; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMPHYSEMA; ENDOTHELIAL DYSFUNCTION; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; GENETIC PREDISPOSITION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOXIA; IMMOBILIZATION; INFLAMMATION; LUNG ALVEOLUS CELL TYPE 2; LUNG CANCER; MAJOR DEPRESSION; MEDICAL RESEARCH; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; QUALITY OF LIFE; RESPIRATORY AIRFLOW; SMOKING CESSATION; ANIMAL; BONE DISEASE; LUNG; LUNG TUMOR; MENTAL DISEASE; METABOLIC DISORDER; PATHOLOGY;

ANIMALS; BONE DISEASES; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; LUNG; LUNG NEOPLASMS; MENTAL DISORDERS; METABOLIC DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77950653061     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000220     Document Type: Article

References (18)

1. Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185.
2. Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J 32: 962-969.
3. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
4. Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59: 574-580.
5. Sin DD, Leung R, Gan WQ, Man SP (2007) Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 7: 13.
6. Ito K, Barnes PJ (2009) COPD as a disease of accelerated lung aging. Chest 135: 173-180.
7. Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370: 797-799.
8. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, et al. (2007) Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 1259-1265.
9. Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, et al. (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180: 513-520.
10. Rutten FH, Vonken EJ, Cramer MJ, Moons KG, Velthuis BB, et al. (2008) Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. Am Heart J 156: 506-512.
11. Watz H, Waschki B, Kirsten A, Muller KC, Kretschmar G, et al. (2009) The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 136: 1039-1046.
12. Lam KB, Jordan RE, Jiang CQ, Thomas GN, Miller MR, et al. (2010) Airflow obstruction and the metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur Respir J 35: 317-323.
13. Jorgensen NR, Schwarz P (2008) Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 14: 122-127.
14. Hung WW, Wisnivesky JP, Siu AL, Ross JS (2009) Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180: 134-137.
15. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, et al. (2009) COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J 34: 380-386.
16. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ (2007) Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 176: 285-290.
17. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, et al. (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142: 233-239.
18. Celli B, Decramer M, Kesten S, Liu D, Mehra S, et al. (2009) Mortality in the 4 Year Trial of Tiotropium (UPLIFT) in Patients with COPD. Am J Respir Crit Care Med 180: 948-955.